Alrex Suspension/ Drops
Product Images NDC 24208-353

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Alrex (NDC 24208-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Alrex

Alrex 0.2% loteprednol etabonate ophthalmic suspension label shows a 10 mL sterile dropper bottle. The label indicates it is for topical ophthalmic use only and includes instructions to shake vigorously before use. Distributed and manufactured by Bausch & Lomb, it lists active and inactive ingredients and storage conditions between 15°C and 25°C (59°F to 77°F).*

FDA Label Image

Chemical Structure

Chemical structure diagram of loteprednol etabonate, showing the molecular formula C24H31ClO7 and molecular weight 466.96.*

FDA Label Image

Image 01

A warning label instructing not to use the product if the neckband imprinted with "Protective Seal" and a yellow mortar and pestle symbol is not intact. This is a safety notice likely related to product sealing and tamper evidence.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.